{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:18:41Z","timestamp":1790705921529,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11095-018-2519-x","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T16:08:14Z","timestamp":1540829294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation"],"prefix":"10.1007","volume":"35","author":[{"given":"Gerard A.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoda","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen M.","family":"Rivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"14","key":"2519_CR1","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"PM Hughes","year":"2005","unstructured":"Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev. 2005;57(14):2010\u201332.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"2519_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17425247.5.5.567","volume":"5","author":"J Barar","year":"2008","unstructured":"Barar J, Javadzadeh AR, Omidi Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv. 2008;5(5):567\u201381.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2519_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1872211308666140130093301","volume":"8","author":"SH Boddu","year":"2014","unstructured":"Boddu SH, Gupta H, Patel S. Drug delivery to the back of the eye following topical administration: an update on research and patenting activity. Recent Pat Drug Deliv Formul. 2014;8(1):27\u201336.","journal-title":"Recent Pat Drug Deliv Formul"},{"issue":"2","key":"2519_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","volume":"99","author":"FG Holz","year":"2015","unstructured":"Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R, et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99(2):220\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2519_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jcp.21426","volume":"216","author":"J Doukas","year":"2008","unstructured":"Doukas J, Mahesh S, Umeda N, Kachi S, Akiyama H, Yokoi K, et al. Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. J Cell Physiol. 2008;216(1):29\u201337.","journal-title":"J Cell Physiol"},{"issue":"1\u20133","key":"2519_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2011.05.016","volume":"666","author":"Y Yafai","year":"2011","unstructured":"Yafai Y, Yang XM, Niemeyer M, Nishiwaki A, Lange J, Wiedemann P, et al. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats. Eur J Pharmacol. 2011;666(1\u20133):12\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2519_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1097\/IAE.0000000000000179","volume":"34","author":"R Singh","year":"2014","unstructured":"Singh R, Wurzelmann JI, Ye L, Henderson L, Hossain M, Trivedi T, et al. Clinical evaluation of pazopanib eye drops in healthy subjects and in subjects with neovascular age-related macular degeneration. Retina. 2014;34(9):1787\u201395.","journal-title":"Retina"},{"issue":"4","key":"2519_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1021\/acs.jmedchem.7b01731","volume":"61","author":"CM Adams","year":"2018","unstructured":"Adams CM, Anderson K, Artman G 3rd, Bizec JC, Cepeda R, Elliott J, et al. The discovery of N-(1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (acrizanib), a VEGFR-2 inhibitor specifically designed for topical ocular delivery, as a therapy for neovascular age-related macular degeneration. J Med Chem. 2018;61(4):1622\u201335.","journal-title":"J Med Chem"},{"issue":"3","key":"2519_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1871527315666151110124957","volume":"15","author":"EY Zernii","year":"2016","unstructured":"Zernii EY, Baksheeva VE, Iomdina EN, Averina OA, Permyakov SE, Philippov PP, et al. Rabbit models of ocular diseases: new relevance for classical approaches. CNS Neurol Disord Drug Targets. 2016;15(3):267\u201391.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2519_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","volume":"137","author":"EM Amo Del","year":"2015","unstructured":"Del Amo EM, Urtti A. Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data. Exp Eye Res. 2015;137:111\u201324.","journal-title":"Exp Eye Res"},{"issue":"4","key":"2519_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jop.2006.0123","volume":"23","author":"GR Owen","year":"2007","unstructured":"Owen GR, Brooks AC, James O, Robertson SM. A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. J Ocul Pharmacol Ther. 2007;23(4):335\u201342.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"2519_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1167\/iovs.13-13650","volume":"55","author":"J Shen","year":"2014","unstructured":"Shen J, Durairaj C, Lin T, Liu Y, Burke J. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2014;55(2):1056\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2519_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/108076804772745419","volume":"20","author":"J Inoue","year":"2004","unstructured":"Inoue J, Oka M, Aoyama Y, Kobayashi S, Ueno S, Hada N, et al. Effects of dorzolamide hydrochloride on ocular tissues. J Ocul Pharmacol Ther. 2004;20(1):1\u201313.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"2519_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1350-9462(01)00018-0","volume":"21","author":"J Ambati","year":"2002","unstructured":"Ambati J, Adamis AP. Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res. 2002;21(2):145\u201351.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"2519_CR15","first-page":"1181","volume":"41","author":"J Ambati","year":"2000","unstructured":"Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41(5):1181\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2519_CR16","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1167\/iovs.08-3148","volume":"50","author":"H Nomoto","year":"2009","unstructured":"Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, et al. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci. 2009;50(10):4807\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2519_CR17","first-page":"1186","volume":"41","author":"J Ambati","year":"2000","unstructured":"Ambati J, Gragoudas ES, Miller JW, You TT, Miyamoto K, Delori FC, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000;41(5):1186\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"2519_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/sj.eye.6701669","volume":"19","author":"KA Williams","year":"2005","unstructured":"Williams KA, Brereton HM, Farrall A, Standfield SD, Taylor SD, Kirk LA, et al. Topically applied antibody fragments penetrate into the back of the rabbit eye. Eye (Lond). 2005;19(8):910\u20133.","journal-title":"Eye (Lond)"},{"issue":"8","key":"2519_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/smll.201303433","volume":"10","author":"BM Davis","year":"2014","unstructured":"Davis BM, Normando EM, Guo L, Turner LA, Nizari S, O'Shea P, et al. Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes. Small. 2014;10(8):1575\u201384.","journal-title":"Small"},{"issue":"10","key":"2519_CR20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3390\/ijms18102076","volume":"18","author":"Chiara Platania","year":"2017","unstructured":"Platania CBM, Fisichella V, Fidilio A, Geraci F, Lazzara F, Leggio GM, et al. Topical ocular delivery of TGF-\u03b21 to the back of the eye: implications in age-related neurodegenerative diseases. Int J Mol Sci. 2017;18(10):2076.","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"2519_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","volume":"61","author":"SB Fonseca","year":"2009","unstructured":"Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev. 2009;61(11):953\u201364.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2519_CR22","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/j.1582-4934.2009.00786.x","volume":"14","author":"Y Wang","year":"2010","unstructured":"Wang Y, Lin H, Lin S, Qu J, Xiao J, Huang Y, et al. Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in rats. J Cell Mol Med. 2010;14(7):1998\u20132005.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2519_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130986","volume":"10","author":"T Ozaki","year":"2015","unstructured":"Ozaki T, Nakazawa M, Yamashita T, Ishiguro S. Delivery of topically applied calpain inhibitory peptide to the posterior segment of the rat eye. PLoS One. 2015;10(6):e0130986.","journal-title":"PLoS One"},{"issue":"7","key":"2519_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.visres.2009.08.028","volume":"50","author":"LN Johnson","year":"2010","unstructured":"Johnson LN, Cashman SM, Read SP, Kumar-Singh R. Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin. Vis Res. 2010;50(7):686\u201397.","journal-title":"Vis Res"},{"issue":"5","key":"2519_CR25","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1167\/iovs.16-20072","volume":"58","author":"F Cogan de","year":"2017","unstructured":"de Cogan F, Hill LJ, Lynch A, Morgan-Warren PJ, Lechner J, Berwick MR, et al. Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides. Invest Ophthalmol Vis Sci. 2017;58(5):2578\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2519_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0192623307310955","volume":"36","author":"BG Short","year":"2008","unstructured":"Short BG. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol. 2008;36(1):49\u201362.","journal-title":"Toxicol Pathol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2519-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:31:46Z","timestamp":1572309106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2519-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2519-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"245"}}